hero banner

hero banner mobile

Per Tablet

Click on image to open expanded view Item No. 52110

Medrol (Methylprednisolone) Tablet, 4 mg Rx

  • In Stock
AutoShip & Save 20%
Save 20% on your 1st AutoShip order and 5% on all future AutoShip orders Learn more

Sorry, there is a manufacturer back order on this item.

You may also like

Product Description
Medrol (Methylprednisolone) is indicated in dogs and cats with conditions known to be responsive to anti-inflammatory corticosteroids, including collagen, dermal, allergic, ocular, otic and musculoskeletal, as well as various chronic or recurrent diseases (ulcerative colitis and nephrosis).
*Sold per tablet.
Who is Medrol (Methylprednisolone) Tablet, 4 mg for?
Dogs or Cats
Why use Medrol (Methylprednisolone) Tablet, 4 mg?
With MEDROL’s enhanced potency, lower doses achieve results similar to prednisone and prednisolone, but reduce the risk of side effects such as polyuria and polydipsia. MEDROL tablets achieve peak serum levels in 1 to 2 hours, to relieve itching quickly. Small, easy-to-swallow tablets are cross-scored for convenient dose adjustments.
How does Medrol (Methylprednisolone) Tablet, 4 mg work?
Medrol (Methylprednisolone) is a glucocorticoid steroid medication used to treat many inflammatory conditions, pets with adrenal gland disease, and pets with immune-mediated diseases. It is similar to but slightly more potent than prednisone / prednisolone.
Active Ingredients(s):
How is Medrol (Methylprednisolone) Tablet, 4 mg sold?
Sold per Tablet 4 mg
What are the side effects of Medrol (Methylprednisolone) Tablet, 4 mg?
With therapeutically equivalent doses, the likelihood of occurrence of troublesome side effects is less with methylprednisolone than with prednisolone; moreover, side effects actually have been conspicuously absent during clinical trials with MEDROL Tablets in dogs and cats. However, methylprednisolone is similar to prednisolone in regard to kinds of side effects and metabolic alterations to be anticipated when treatment is intensive or prolonged. In animal patients with diabetes mellitus, use of methylprednisolone may be associated with an increase in the insulin requirement. Negative nitrogen balance may occur, particularly in animals that require protracted maintenance therapy; measures to counteract persistent nitrogen loss include a high protein intake and the administration when indicated, of a suitable anabolic agent. Excessive loss of potassium, like excessive retention of sodium, is not likely to be induced by effective maintenance doses of MEDROL. However, these effects should be kept in mind and the usual regulatory measures employed as indicated. Ecchymotic manifestations, while not noted during the clinical evaluation in dogs and cats, may occur. If such reactions do occur and are serious, reduction in dosage or discontinuance of methylprednisolone therapy may be indicated. Concurrent use of daily oral supplements of ascorbic acid may be of value in helping to control ecchymotic tendencies. Since methylprednisolone, like prednisolone, suppresses endogenous adrenocortical activity, it is highly important that the animal patient receiving MEDROL be under careful observation, not only during the course of treatment but for some time after treatment is terminated. Adequate adrenocortical supportive therapy with cortisone or hydrocortisone, and including ACTH, must be employed promptly if the animal is subjected to any unusual stress such as surgery, trauma, or severe infection.
What special precautions are there?
Keep away from children and animals. Not for human use. Because of its inhibitory effect on fibroplasia, methylprednisolone may mask the signs of infection and enhance dissemination of the infecting organism. Hence, all animal patients receiving methylprednisolone should be watched for evidence of intercurrent infection. Should infection occur, it must be brought under control by use of appropriate antibacterial measures, or administration of methylprednisolone should be discontinued. MEDROL Tablets, like prednisolone and other adrenocortical steroids is a potent therapeutic agent influencing the biochemical behavior of most, if not all, tissues of the body. Because this anti-inflammatory steroid manifests little sodium-retaining activity, the usual early sign of cortisone or hydrocortisone overdosage (ie, increase in body weight due to fluid retention) is not a reliable index of overdosage. Hence, recommended dose levels should not be exceeded, and all animal patients receiving MEDROL should be under close medical supervision. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia, and anasarca.
What to do if overdose?
Contact your nearest emergency animals hospital.
How can I store Medrol (Methylprednisolone) Tablet, 4 mg?
Store at controlled room temperature 20° to 25° C (68° to 77° F).
Use as directed by your Veterinarian.
Main Ingredients